Skip to main content
Ronald Levy, MD, Oncology, Stanford, CA

Ronald Levy MD


Professor, Medicine - Oncology, Stanford University Medical Center

Join to view full profile
  • 300 Pasteur DrStanford, CA 94305

  • Phone+1 650-723-4000

Join Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 7 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Ronald Levy, MD is an oncologist in Stanford, California. He is currently licensed to practice medicine in California. He is a Professor at Stanford University Medical Center.

Education & Training

  • Sutter Health/California Pacific Medical Center
    Sutter Health/California Pacific Medical CenterResidency, Gastroenterology, 2020 - 2026
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1971 - 1973
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1968 - 1970
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1968

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1972 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017

Publications & Presentations

PubMed

Press Mentions

  • In-Body CAR-T Therapy Offers Real-Time Monitoring and Lower Toxicity
    In-Body CAR-T Therapy Offers Real-Time Monitoring and Lower ToxicityJuly 23rd, 2025
  • Prior Treatment with Cancer Drug Likely Renders COVID-19 Vaccine Ineffective, Study Finds
    Prior Treatment with Cancer Drug Likely Renders COVID-19 Vaccine Ineffective, Study FindsFebruary 2nd, 2022
  • How COVID-19 Vaccine Strategy Could Combat Other Diseases
    How COVID-19 Vaccine Strategy Could Combat Other DiseasesDecember 18th, 2020

Grant Support

  • Mechanisms of HIV fitness and drug resistance inferred from high-resolution molecular dynamics and sequence co-variation modelsTEMPLE UNIV OF THE COMMONWEALTH2023–2028
  • Mechanisms of HIV fitness and drug resistance inferred from high-resolution molecular dynamics and sequence co-variation modelsTEMPLE UNIV OF THE COMMONWEALTH2023–2028
  • Mapping Fitness & Free Energy Landscapes of ProteinsTEMPLE UNIV OF THE COMMONWEALTH2019–2027
  • Mapping Fitness & Free Energy Landscapes of ProteinsTEMPLE UNIV OF THE COMMONWEALTH2019–2027
  • Imaging Modulation of Immune PhenotypeSTANFORD UNIVERSITY2021–2026